Barclays Reiterates an 'Overweight' on Entropic (ENTR); Believe 1Q Broadly on Track
Tweet Send to a Friend
Barclays reiterates an 'Overweight' on Entropic (NASDAQ: ENTR), PT $14.
Barclays analyst says, "Following recent weakness, we update our outlook ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Following recent weakness, we update our outlook ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
